1. Home
  2. ATYR vs EPSN Comparison

ATYR vs EPSN Comparison

Compare ATYR & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.83

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$6.03

Market Cap

132.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
EPSN
Founded
2005
2005
Country
United States
Canada
Employees
59
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
132.1M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ATYR
EPSN
Price
$0.83
$6.03
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
1.1M
234.8K
Earning Date
03-05-2026
05-13-2026
Dividend Yield
N/A
4.14%
EPS Growth
N/A
N/A
EPS
N/A
0.30
Revenue
N/A
N/A
Revenue This Year
N/A
$41.35
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.18
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$4.20
52 Week High
$7.29
$8.50

Technical Indicators

Market Signals
Indicator
ATYR
EPSN
Relative Strength Index (RSI) 43.59 70.67
Support Level $0.82 $4.62
Resistance Level $0.85 $6.49
Average True Range (ATR) 0.06 0.22
MACD -0.02 0.04
Stochastic Oscillator 17.50 83.76

Price Performance

Historical Comparison
ATYR
EPSN

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: